Covax

Rediff.com » News » Covax

News for Covax

News
Business

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

Modi calls for reforming WHO at 2nd global Covid summit

Prime Minister Narendra Modi on Thursday called for reforming the World Health Organisation and streamlining its approval process for vaccines and therapeutics, and favoured making flexible the......

Bharat Biotech to rectify issues with Covaxin raised by WHO

Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organisation regarding its COVID-19 vaccine -- Covaxin -- in a few days and added that the......

Rapid spread of Omicron, social mixing may spurt cases in coming weeks: WHO

The World Health Organisation has warned that increased and rapid spread of the Omicron variant, combined with greater social mixing around the end of year holiday period and challenges with......

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Biopharmaceutical multinational AstraZeneca on Thursday said the preliminary analysis of an ongoing safety and immunogenicity trial has indicated that Vaxzevria, when given as a third dose booster,......

Indian economy to grow at 9.5% this year and 8.5% in 2022: IMF

India's economy, which contracted by 7.3 per cent due to the COVID-19 pandemic, is expected to grow by 9.5 per cent in 2021 and 8.5 per cent in 2022, according to latest projections released by the......

Invest in Aurobindo Pharma only for a long term

The focus of the company would be to develop its capability across segments of injectables, vaccines, biosimilars, inhalation and APIs to drive growth. Aurobindo Pharma’s December-quarter......

How govt plans to distribute Covid-19 vaccine

The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......

Serum Institute to provide Covid vaccine at Rs 250 a dose

Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Rediff News

Covax

News for Covax

AstraZeneca's COVID-19 Vaccine: The TTS Factor

Modi calls for reforming WHO at 2nd global Covid summit

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rapid spread of Omicron, social mixing may spurt cases in coming weeks: WHO

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Indian economy to grow at 9.5% this year and 8.5% in 2022: IMF

Invest in Aurobindo Pharma only for a long term

How govt plans to distribute Covid-19 vaccine

Serum Institute to provide Covid vaccine at Rs 250 a dose

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS